Human Immunodeficiency Virus Type 1 (HIV-1) (glycosylated) Antikörper

Produktnummer ABIN112973

Der Ziege Polyklonal anti-Human Immunodeficiency Virus Type 1 Antikörper wird verwendet zum Nachweis von Human Immunodeficiency Virus Type 1 in Proben von Human Immunodeficiency Virus (HIV). Er wurde validiert für WB, EIA, IF und IHC (fro).

Kurzübersicht für Human Immunodeficiency Virus Type 1 (HIV-1) (glycosylated) Antikörper (ABIN112973)

Target: Human Immunodeficiency Virus Type 1 (HIV-1)

Reaktivität: Human Immunodeficiency Virus (HIV)

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Unkonjugiert

Applikation: Western Blotting (WB), Enzyme Immunoassay (EIA), Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))

Produktdetails

Bindungsspezifität: glycosylated

Aufreinigung: Sodium Sulfate Precipitation and Ion Exchange Chromatography.

Immunogen: Recombinant (P. Pastoris) ectodomain of gp41 (glycosylated)

Anwendungsinformationen

Applikationshinweise: ELISA. Western blot: 1/1000. Immunofluorescence Microscopy. Immunohistochemistry on Frozen Tissues.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 4-5 mg/mL (OD280 nm, E0.1% = 1.4)

Buffer: 0.01 M PBS, pH 7.2 with 0.09 % Sodium Azide as preservative without stabilizing proteins.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Antigendetails

Target: Human Immunodeficiency Virus Type 1 (HIV-1)

Andere Bezeichnung: HIV-1

Substanzklasse: Virus

Hintergrund: HIV is a highly variable virus which mutates very readily. This means there are many different strains of HIV, even within the body of a single infected person. The strains of HIV1 can be classified into three groups : the "major" group M, the "outlier" group O and the "new" group N. These three groups may represent three separate introductions of simian immunodeficiency virus into humans. Group O appears to be restricted to West-Central Africa and group N, discovered in 1998 in Cameroon, is extremely rare. More than 90 % of HIV1 infections belong to HIV1 group M.Synonyms: HIV-I, HIV1, Human immunodeficiency virus type 1